All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-35707000

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	35707000	A23063T	S	S	COVID-19	R	View
2	35707000	A23403G	S	S	COVID-19	R	View
3	35707000	D614G	S	S	COVID-19	R	View
4	35707000	N501Y	S	S	COVID-19	R	View
5	35707000	G25563T	ORF3a	ORF3a	COVID-19	R	View
6	35707000	Q57H	ORF3a	ORF3a	COVID-19	R	View
7	35707000	C10376T	NSP5	ORF1a	COVID-19	R	View
8	35707000	P108S	NSP5	ORF1a	COVID-19	R	View
9	35707000	A423V	NSP12	ORF1b	COVID-19	R	View
10	35707000	C14408T	NSP12	ORF1b	COVID-19	R	View
11	35707000	C14708T	NSP12	ORF1b	COVID-19	R	View
12	35707000	P323L	NSP12	ORF1b	COVID-19	R	View
13	35707000	C28725T	N	N	COVID-19	R	View
14	35707000	G204R	N	N	COVID-19	R	View
15	35707000	G28881A	N	N	COVID-19	R	View
16	35707000	G28882A	N	N	COVID-19	R	View
17	35707000	G28883C	N	N	COVID-19	R	View
18	35707000	P151L	N	N	COVID-19	R	View
19	35707000	R203K	N	N	COVID-19	R	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.